Study acronym: CamProS-PC
Short Tile: Cambridge Prospective Cohort Study of Surgical Treatment of Patients with Symptomatic Pineal Cyst
Full Scientific Title: Assessment of changes in quality of life and symptoms over time in patients with symptomatic pineal cyst treated with surgery or conservatively – a prospective observational cohort study
Sponsor: Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
Study Participants: Patients with symptomatic pineal cysts (SPCs)
Planned Sample Size: 40 surgically treated patients and all conservatively treated patients at the same period
Planned Study Period: Up to 5 years
Primary Objective: Assessment of the impact of surgery on quality of life, specifically patients’ role functioning at one year after resection of symptomatic pineal cyst
Secondary Objectives:
- Assessment of all aspects of quality of life as defined by the EORTC QLQ-C30 questionnaire at 1 year and also at 2 and 3 years after surgery.
- Assessment of symptoms at 1 year and also at 2 and 3 years after surgery.
- Assessment of all aspects of quality of life and symptoms in patients who did not undergo surgery (= conservative management) at the time of diagnosis and at 1, 2 and 3 years after joining the study; and investigation the differences at baseline and follow up between those treated surgically and conservatively.
- Comparison of objective neuropsychological assessments before the operation and at 1 year after surgery.
- Development of a model to identify anatomical (based in MRI scans) and clinical (symptoms) predictors of improvement of QoL after surgery for SPC
Study design: Prospective observational cohort study
Interventions: No interventions. This is an observational study
Study type: Safety, Efficacy
Participant inclusion criteria:
- age ≥18 years
- presence of a PC of size >10mm
- presence of severe symptoms consistent with the syndrome of nhSPC, defined as ≥6/10 on Eide- Ringstad pineal cyst symptom severity scale (Eide & Ringstad Acta Neurochirurgica, 2017)
- ≥6 months of conservative treatment without improvement
Participant exclusion criteria:
- radiological evidence of ventriculomegaly
- other diagnosis of CNS pathology
- precious intracranial neurosurgical intervention
IRAS Project ID: 292313
REC Reference: 21/NI/0120
Health Research Authority Approval Letter:
Recruitment start date: July 2021
Recruitment end date: May 2023
Number of patients recruited: 40
Study Protocol:
2022 Amendment:
Study documents
Participant Information Sheet:
Participant Consent:
Quality of life questionnaire – EORTC-QLQ-C30 (used at each time point, i.e. before the operation, at 3 months, 12 months, 24 months etc after the operation )
Pre-operative symptom questionnaire:
Post-operative questionnaires:
Current status (last update 6/12/2024): data analysis
Related publications:

